FY2024 Earnings Estimate for Masimo Issued By Zacks Research

Masimo Co. (NASDAQ:MASI) – Stock analysts at Zacks Research issued their FY2024 earnings per share (EPS) estimates for Masimo in a research note issued to investors on Wednesday, February 19th. Zacks Research analyst I. Bandyopadhyay anticipates that the medical equipment provider will post earnings per share of $4.10 for the year. The consensus estimate for Masimo’s current full-year earnings is $4.10 per share. Zacks Research also issued estimates for Masimo’s Q4 2024 earnings at $1.49 EPS.

Several other analysts also recently commented on MASI. Piper Sandler upped their price objective on Masimo from $180.00 to $210.00 and gave the company an “overweight” rating in a research note on Wednesday, December 18th. Needham & Company LLC reiterated a “hold” rating on shares of Masimo in a research report on Wednesday, January 22nd. Stifel Nicolaus reaffirmed a “buy” rating and issued a $190.00 target price (up from $170.00) on shares of Masimo in a report on Friday, November 22nd. Wells Fargo & Company increased their price target on shares of Masimo from $171.00 to $193.00 and gave the company an “overweight” rating in a research report on Wednesday, December 11th. Finally, Raymond James increased their price target on shares of Masimo from $170.00 to $194.00 and gave the company an “outperform” rating in a research report on Friday, December 27th. Two research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $191.40.

Masimo Stock Down 0.7 %

Masimo stock opened at $169.54 on Monday. The stock’s fifty day moving average is $172.65 and its two-hundred day moving average is $152.54. The stock has a market cap of $9.08 billion, a PE ratio of 116.92 and a beta of 1.02. Masimo has a 1-year low of $101.61 and a 1-year high of $184.51. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.01 and a quick ratio of 1.11.

Masimo (NASDAQ:MASI) last posted its quarterly earnings results on Tuesday, February 25th. The medical equipment provider reported $1.80 earnings per share for the quarter, beating analysts’ consensus estimates of $1.42 by $0.38. Masimo had a return on equity of 14.98% and a net margin of 3.85%.

Institutional Investors Weigh In On Masimo

Several hedge funds and other institutional investors have recently added to or reduced their stakes in MASI. Jones Financial Companies Lllp purchased a new stake in Masimo during the 4th quarter worth $27,000. UMB Bank n.a. increased its stake in Masimo by 180.9% during the 4th quarter. UMB Bank n.a. now owns 191 shares of the medical equipment provider’s stock worth $32,000 after buying an additional 123 shares during the period. Trust Co. of Vermont purchased a new stake in Masimo during the 4th quarter worth $33,000. Blue Trust Inc. increased its stake in Masimo by 56.3% during the 4th quarter. Blue Trust Inc. now owns 197 shares of the medical equipment provider’s stock worth $33,000 after buying an additional 71 shares during the period. Finally, EverSource Wealth Advisors LLC grew its holdings in Masimo by 40.0% during the 4th quarter. EverSource Wealth Advisors LLC now owns 224 shares of the medical equipment provider’s stock worth $37,000 after acquiring an additional 64 shares in the last quarter. Hedge funds and other institutional investors own 85.96% of the company’s stock.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.